A carregar...
How I monitor residual disease in chronic myeloid leukemia
Molecular monitoring in chronic myeloid leukemia (CML) is a powerful tool to document treatment responses and predict relapse. Nonetheless, the proliferation of clinical trials and “guidelines” using the molecular endpoints of CML has outpaced practice norms, commercial laboratory application, and r...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3654782/ https://ncbi.nlm.nih.gov/pubmed/19661271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-02-163485 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|